MbrlCatalogueTitleDetail

Do you wish to reserve the book?
IDDF2024-ABS-0199 ELOVL fatty acid elongase 1 facilitates NAFLD-related HCC progression by shaping immunosuppressive tumor microenvironment via GPNMB+ M2-like macrophages
IDDF2024-ABS-0199 ELOVL fatty acid elongase 1 facilitates NAFLD-related HCC progression by shaping immunosuppressive tumor microenvironment via GPNMB+ M2-like macrophages
Hey, we have placed the reservation for you!
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
IDDF2024-ABS-0199 ELOVL fatty acid elongase 1 facilitates NAFLD-related HCC progression by shaping immunosuppressive tumor microenvironment via GPNMB+ M2-like macrophages
Oops! Something went wrong.
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Title added to your shelf!
Title added to your shelf!
View what I already have on My Shelf.
Oops! Something went wrong.
Oops! Something went wrong.
While trying to add the title to your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
IDDF2024-ABS-0199 ELOVL fatty acid elongase 1 facilitates NAFLD-related HCC progression by shaping immunosuppressive tumor microenvironment via GPNMB+ M2-like macrophages
IDDF2024-ABS-0199 ELOVL fatty acid elongase 1 facilitates NAFLD-related HCC progression by shaping immunosuppressive tumor microenvironment via GPNMB+ M2-like macrophages

Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
How would you like to get it?
We have requested the book for you! Sorry the robot delivery is not available at the moment
We have requested the book for you!
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
IDDF2024-ABS-0199 ELOVL fatty acid elongase 1 facilitates NAFLD-related HCC progression by shaping immunosuppressive tumor microenvironment via GPNMB+ M2-like macrophages
IDDF2024-ABS-0199 ELOVL fatty acid elongase 1 facilitates NAFLD-related HCC progression by shaping immunosuppressive tumor microenvironment via GPNMB+ M2-like macrophages
Journal Article

IDDF2024-ABS-0199 ELOVL fatty acid elongase 1 facilitates NAFLD-related HCC progression by shaping immunosuppressive tumor microenvironment via GPNMB+ M2-like macrophages

2024
Request Book From Autostore and Choose the Collection Method
Overview
BackgroundNon-alcoholic fatty liver disease (NAFLD) is increasingly recognized as a risk for hepatocellular carcinoma (HCC). The core of NAFLD pathogenesis is primarily associated with dysregulated lipid metabolism, which leads to lipid accumulation within hepatocytes. It not only contributes to lipotoxicity as a potential oncogenic evolution towards HCC, but also underpins immune evasion within the tumor microenvironment. Recent studies have identified the elongation of fatty acids, predominantly mediated by the ELOVL family of enzymes, as a contributing factor in the progression of NAFLD. Nevertheless, the implications of ELOVL activity in the transition from NAFLD to HCC are not yet fully elucidated.MethodsMouse CRISPR/dCas9-mediated transcriptional activation library screening systems were applied to determine the key targets in the progression of NAFLD-HCC in mouse models. RNA-sequencing analysis were used to explore the crucial signalling pathway. A comprehensive analysis of ELOVL1 expression in the NAFLD-HCC local cohort were performed. DEN or transgenic TP53KO/MycOE mouse with high-fat methionine-choline-deficient diet (HFMCD) induced NAFLD-HCC model were established to explore the role of ELOVL1 on tumor progression.ResultsELOVL1 was a top candidate in the NAFLD-HCC orthotopic mouse model among fatty acid elongation family by CRISPR-dCas9 screening. RNA-seq data and local clinical samples showed that ELOVL1 expression was significantly induced in NAFLD-HCC (IDDF2024-ABS-0199-Figure 1. ELOVL1 was upregulated in NAFLD HCC and crucial for NAFLD HCC progression in vivo). The increased expression of ELOVL1 was correlated with poor overall survival (OS) and less CD8+ T cells infiltration in the local cohort (IDDF2024-ABS-0199 Figure 2. ELOVL1 was overexpressed in NAFLD HCC with poor clinical features and less CD8 T cells infiltration). ELOVL1 knockdown could inhibit HCC growth in HFMCD-induced NAFLD-HCC models and alleviate the fibrosis level in the liver context (IDDF2024-ABS-0199 Figure 3. ELOVL1 knockdown inhibited HCC growth in HFMCD-induced NAFLD HCC models). ELOVL1 knockdown inhibited hepatocarcinogenesis and reshaped immune cells infiltration profile with less CD206+IL10+ mφ and more TNF-α/IFN-γ CD8+ T cells infiltration (IDDF2024-ABS-0199 Figure 4. ELOVL1 knockdown inhibited hepatocarcinogenesis and reshaped immune cells infiltration profile). Cell sorting and RNA-seq demonstrated that GPNMB+ mφ infiltration was the main cause of ELOVL1-promoting tumor growth (IDDF2024-ABS-0199 Figure 5. GPNMB macrophages infiltration accounted for ELOVL1-promoting tumor growth).ConclusionsELOVL1 reshapes the immune cell profile in the tumor microenvironment with a high infiltration of GPNMB+ M2-like macrophages, which may diminish CD8+ T cell anti-tumor immunity and accelerate NAFLD-HCC progression.Abstract IDDF2024-ABS-0199 Figure 1ELOVL1 was upregulated in NAFLD HCC and crucial for NAFLD HCC progression in vivoAbstract IDDF2024-ABS-0199 Figure 2ELOVL1 was overexpressed in NAFLD HCC with poor clinical features and less CD8 T cells infiltrationAbstract IDDF2024-ABS-0199 Figure 3ELOVL1 knockdown inhibited HCC growth in HFMCD-induced NAFLD HCC modelsAbstract IDDF2024-ABS-0199 Figure 4ELOVL1 knockdown inhibited hepatocarcinogenesis and reshaped immune cells infiltration profileAbstract IDDF2024-ABS-0199 Figure 5GPNMB macrophages infiltration accounted for ELOVL1-promoting tumor growth